We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
China's Antengene has raised $120 million in its second financing round, with a contribution from partner Celgene. Otsuka has signed Click Therapeutics in a digital medicine deal potentially worth $305 million. Chinese firms MabSpace and HJB have merged t
China's Antengene has raised $120 million in its second financing round, with a contribution from partner Celgene. Otsuka has signed Click Therapeutics in a digital medicine deal potentially worth $305 million. Chinese firms MabSpace and HJB have merged t